戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n impaired executive function and relapse in cocaine dependence.
2  IRX2 in neuronal nuclei was associated with cocaine dependence.
3 iatal dysmorphology in patients with chronic cocaine dependence.
4 t not in short-term outcome of treatment for cocaine dependence.
5 ocaine, a period of high risk for relapse in cocaine dependence.
6 atients in clinical trials of medication for cocaine dependence.
7 ransmission in chronic neural adaptations to cocaine dependence.
8 ing and GDC has promise for the treatment of cocaine dependence.
9 reatment outcomes of community treatments of cocaine dependence.
10 important considerations in the treatment of cocaine dependence.
11 n and withdrawal effects in animal models of cocaine dependence.
12  medications to treat one or more aspects of cocaine dependence.
13 tients with comorbid depressive disorder and cocaine dependence.
14 lication in developing a pharmacotherapy for cocaine dependence.
15 and completion among depressed patients with cocaine dependence.
16 enous opioids has important implications for cocaine dependence.
17 outpatients who meet the DSM-IV criteria for cocaine dependence.
18 bstance use diagnoses, most often opioid and cocaine dependence.
19 sing therapeutic candidate for prevenance of cocaine dependence.
20 fective pharmacological treatments to combat cocaine dependence.
21 ort the role of NSF in the susceptibility to cocaine dependence.
22 ptors have been suggested as medications for cocaine dependence.
23 buting to decreased dopamine transmission in cocaine dependence.
24 coline in patients with bipolar disorder and cocaine dependence.
25 o conclusively rule out neuroinflammation in cocaine dependence.
26 icits in cognitive control are implicated in cocaine dependence.
27 nt might be an effective pharmacotherapy for cocaine dependence.
28 ne D(2/3) transmission involve the cortex in cocaine dependence.
29  established as an efficacious treatment for cocaine dependence.
30 titute two prominent strategies for treating cocaine dependence.
31 by the opposite directions of risk allele in cocaine dependence.
32 disorder, depressed or mixed mood state, and cocaine dependence.
33 rol purpose in a large case-control study of cocaine dependence.
34 ng might serve as a therapeutic strategy for cocaine dependence.
35  effects may be relevant in the treatment of cocaine dependence.
36 tment with methylphenidate for patients with cocaine dependence.
37 psychological treatments for amphetamine and cocaine dependence.
38  actively using cocaine and had a history of cocaine dependence.
39  the emotional dysregulation associated with cocaine dependence.
40 n response to CRH was independent of sex and cocaine dependence.
41 ficacy of short-term vigabatrin treatment of cocaine dependence.
42 e use of N-acetylcysteine as a treatment for cocaine dependence.
43 ns in dopamine function might be involved in cocaine dependence.
44  next step to increase the ability to manage cocaine dependence.
45  of benefit in improving relapse outcomes in cocaine dependence.
46 compound for agonist substitution therapy in cocaine dependence.
47 arijuana dependence, 1,262 with histories of cocaine dependence, 647 with amphetamine dependence, and
48 ch compared four psychosocial treatments for cocaine dependence, a three-item craving questionnaire w
49 drug attentional bias effect associated with cocaine dependence (AB-coc) using a word counting Stroop
50     No effective pharmacotherapies exist for cocaine dependence, although contingency management (CM)
51 eatment-seeking cocaine users (CUs) (52 with cocaine dependence and 3 with cocaine abuse) and 56 heal
52 patients with bipolar I disorder and current cocaine dependence and active cocaine use.
53                                        Crack cocaine dependence and addiction is typically associated
54 s brain FC and the subsequent development of cocaine dependence and brain changes during abstinence.
55 volvement of the endogenous opioid system in cocaine dependence and cocaine craving in living human s
56                      Alcohol, marijuana, and cocaine dependence and habitual smoking are all familial
57 lial transmission of alcohol, marijuana, and cocaine dependence and habitual smoking in the Collabora
58             Rates of alcohol, marijuana, and cocaine dependence and habitual smoking were increased i
59  to mediate the relationship between chronic cocaine dependence and molecular changes in addiction-re
60 indicator, based on co-occurring alcohol and cocaine dependence and poor progress toward achieving in
61 5-HT(1B)Rs may lead to a novel treatment for cocaine dependence and that the therapeutic efficacy of
62 trols) and identified an association between cocaine dependence and the CNV (P = 0.013), that was con
63 al lobes of subjects with a history of crack cocaine dependence and to determine whether these change
64  importance of social-emotional functions in cocaine dependence, and provides a potential underlying
65 , no approved pharmacological treatments for cocaine dependence are available to assist addicts to ov
66 odynamic (PD), and predictive biomarkers for cocaine dependence are discussed across a range of metho
67                   At present, biomarkers for cocaine dependence are in their infancy.
68                                  We focus on cocaine dependence as an example.
69 4 control subjects), and the Family Study of Cocaine Dependence (ascertained for cocaine use disorder
70 cohol dependence (B = 0.231, p < 0.001), and cocaine dependence (B = 0.086, p < 0.01) in EA individua
71 esent intriguing candidates for the study of cocaine dependence because nicotinic receptors are thoug
72 lexibility of BG2 with three case studies on cocaine dependence (binary data), alcohol consumption (c
73 ram has emerged as a promising treatment for cocaine dependence, but it has not yet been evaluated in
74 condition that predisposes the individual to cocaine dependence by affecting the amygdala, or a prima
75  measurement of craving during treatment for cocaine dependence can monitor patients' clinical status
76 striatal D(2)/D(3 )receptors associated with cocaine dependence cannot be attributed to higher levels
77 lthough craving states are important to both cocaine dependence (CD) and pathological gambling (PG),
78                                              Cocaine dependence (CD) and related behaviors are highly
79 t a genome-wide association study (GWAS) for cocaine dependence (CD) in three sets of African- and Eu
80 nctional alterations in reward processing in cocaine dependence (CD) pretreatment and posttreatment t
81  vivo in subjects whose primary addiction is cocaine dependence (CD) using positron emission tomograp
82  not been studied previously in persons with cocaine dependence (CD).
83 the largest genome-wide association study of cocaine dependence (CD; n = 6546; 82.37% with CD; 57.39%
84  may be related to the clinical phenotype of cocaine dependence characterized by impulsive behaviours
85 st-would result in efficacious treatment for cocaine dependence compared with placebo.
86 A5-CHRNA3-CHRNB4, in a case-control study of cocaine dependence composed of 504 European-American and
87 psychosocial approaches for the treatment of cocaine dependence: contingency management (CM) and cogn
88                                           In cocaine dependence, corticostriatal-limbic hyperactivity
89 tive pharmacological agents for treatment of cocaine dependence depends on this knowledge.
90 firam might not be an effective treatment of cocaine dependence for individuals with this variant.
91                                              Cocaine dependence has been associated with blunted dopa
92                                              Cocaine dependence impacts drug-related, dopamine-depend
93                  Onset preceded the onset of cocaine dependence in 72.0% of the patients (and precede
94 hy volunteers (n=40), persons diagnosed with cocaine dependence in early abstinence (<2 months, EACD)
95 RBS) to generate a methylome-wide profile of cocaine dependence in human post-mortem caudate tissue.
96 orphisms in the CACNA1D gene associated with cocaine dependence in human subjects.
97 ticoline was well tolerated for treatment of cocaine dependence in patients with bipolar disorder.
98 have both shown promise for the treatment of cocaine dependence in preclinical and early-stage clinic
99 eviously, we identified a risk haplotype for cocaine dependence in the NSF gene, encoding the protein
100                                              Cocaine dependence involves problematic neuroadaptations
101                                              Cocaine dependence is a complex psychiatric disorder inv
102                                              Cocaine dependence is a pervasive disorder with high rat
103                                              Cocaine dependence is a serious world-wide public health
104                                              Cocaine dependence is a significant public health proble
105                                              Cocaine dependence is a substantial public health proble
106 for sex-specific strategies for treatment of cocaine dependence is also furnished by the findings of
107 (PET) imaging studies have demonstrated that cocaine dependence is associated with a decrease in dopa
108                                              Cocaine dependence is associated with abnormalities in b
109                                              Cocaine dependence is associated with high rates of rela
110                                              Cocaine dependence is associated with impairment of dopa
111                                              Cocaine dependence is associated with severe medical, ps
112 graphy (PET) imaging studies have shown that cocaine dependence is associated with the dysregulation
113                                              Cocaine dependence is characterized by compulsive drug t
114                                        While cocaine dependence is prevalent and disabling in women,
115                     Relapse vulnerability in cocaine dependence is rooted in genetic and environmenta
116                              For example, in cocaine dependence, low dopamine release is associated w
117 tions in the retina, we investigated whether cocaine dependence may be associated with abnormalities
118 its in dopaminergic function associated with cocaine dependence may contribute to striatal hypertroph
119 acy of opioid medications to treat opioid or cocaine dependence may differ by sex.
120 se drug craving and contribute to relapse in cocaine dependence, no previous research has directly ex
121          Eight volunteers with active DSM-IV cocaine dependence not seeking treatment or abstinence w
122 ere we examined the possible contribution to cocaine dependence of a large copy number variant (CNV)
123 nce, especially for patients with concurrent cocaine dependence or abuse.
124 8 years or older, met criteria for opioid or cocaine dependence, or both, in the past 12 months, and
125 disorder (depressed or mixed mood state) and cocaine dependence received citicoline or placebo add-on
126  probands had an elevated risk of developing cocaine dependence (RR, 1.71).
127                                        Thus, cocaine dependence seems to engender increased responsiv
128 ffects are a consequence of or antecedent to cocaine dependence, they likely have implications for th
129 ibutes to the development and maintenance of cocaine dependence through alterations in 3D chromatin s
130 ruited 97 treatment-seeking individuals with cocaine dependence to perform the stop signal task durin
131 ciple, a promising therapeutic candidate for cocaine dependence treatment may alter the cocaine pharm
132                                              Cocaine dependence was associated with a marked reductio
133                                              Cocaine dependence was associated with an extensive syst
134                          Greater duration of cocaine dependence was correlated with greater grey matt
135 (5-year) outcomes of community treatment for cocaine dependence were examined in relation to problem
136  in 8 cities) who met DSM-III-R criteria for cocaine dependence when admitted to treatment in 1991-19
137                                              Cocaine dependence, which affects 2.5 million Americans
138 treatment for most patients with alcohol and cocaine dependence who complete an initial stabilization
139                                Patients with cocaine dependence who were receiving methadone maintena
140 llars per year, if developed, biomarkers for cocaine dependence will hold tremendous value to both in
141 in-B) reduces several behavioral measures of cocaine dependence, without altering motor performance o

 
Page Top